Antibiotic resistance pattern in uropathogens at a tertiary care hospital at jhalawar with special reference to ESBL, AmpC β-lactamase and MRSA production

Journal of Clinical and Diagnostic Research

Volumn 6, Issue 4 SUPPL. 2, 2012, Pages 645-651

  Dalela, Gaurav ^a   Sweta, Gupta ^b   Jain, Dinesh Kumar ^a   Mehta, Pushpa ^a  

^a Jhalawar Medical College   (India)

^b GANDHI MEDICAL COLLEGE   (India)

Author keywords

AmpC lactamase; Antibiotic resistance; ESBL; MRSA; UTI

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAMASE AMPC; CEFALEXIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; COTRIMOXAZOLE; DOXYCYCLINE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LINEZOLID; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ACINETOBACTER; AMPC DISK TEST; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CITROBACTER; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXACILLIN E TEST; PHENOTYPE; PHENOTYPIC CONFIRMATORY DISC DIFFUSION TEST; PROTEUS MIRABILIS; PROTEUS VULGARIS; PROVIDENCIA; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION;

EID: 84873349629     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Tice AD. Short course therapy of acute cystitis: a brief review of the therapeutic strategies. J Antimicrob Chemother 1999; 43:85-93.
2. Clarridge JE, Johnson JR, Pezzio MT. Cumitech 2B, Laboratory diagnosis of Urinary tract infections, (Weissfeld, A.S., Ed.). American society for Microbiology, Washington, DC.
3. Sussman M. Urinary tract infections. In Topley and Wilson's Microbiology and Microbial infections, 9th edition, (Collier L., Balows A., Sussman M., Eds), pp. 601-21. Amold, London.
4. Khameneh ZR, Afshar AT. Antimicrobial susceptibility pattern of urinary tract pathogens. Saudi J Kidney Dis Transpl 2009;20:251-53.
5. Clinical and Laboratory Standards Iinstitute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement ed. CLSI document M100-S20. Wayne, PA:CLSI; 2010.
6. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S et al. Evaluation of the methods for AmpC β-lactamase in gram negative clinical isolates from tertiary care hospitals. Ind J Med Microbiol 2005; 23 (2):120-24.
7. ABBIODISK. E-test oxacillin package insert. Solna, Sweden: ABBIODISK; 2011.
8. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281:517-23.
9. Thompson KS. Contoversies about extended-spectrum and AmpC β-lactamases. Emerg Infect Dis 2001; 7:333-36.
10. Subha A, Ananthan S. Extended-spectrum β-lactamase (ESBL) mediated resistance to the third generation cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiol 2002; 20:92-95.
11. Babypadmini S, Appalaraju B. Extended-spectrum β-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility patterns in a tertiary care hospital. Indian J Med Microbiol 2004; 22(3): 172-74.
12. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum β-lactamase producing gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002; 115:153-57.
13. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, et al. Evaluation ofmethods for AmpC β-lactamase in gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol 2005; 23(2):120-24.
14. Rodrigues C, Joshi P, Jani SH, Alphonse M, Radhakrishnan R, et al. Detection of β-lactamases in nosocomial, gram negative, clinical isolates. Indian J Med Microbiol 2004; 22(4):247-50.
15. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: the hospital prevalence and the susceptibility patterns. Rev Infect Dis 1988; 10:867-78.
16. Tankhiwale SS, Jalgaonkar SV, Ahamad S, Hassani U. Evaluation of extended spectrum beta lactamases in urinary isolates. Indian J Med Res 2004; 120:553-56.
17. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18:306-25.
18. Noyal MJ, Menezes GA, Harish BN, Sujatha S, Parija SC. Simple screening tests for the detection of carbapenemases in clinical isolates of non-fermentative gram-negative bacteria. Indian J Med Res 2009; 129:707-12.
19. Sturenburg E, Mack D. Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 2003; 47: 273-95.
20. Shubha A, Devi VR, Ananthan S. AmpC beta-lactamase producing multidrug resistant strains of Klebsiella spp. and Escherichia coli which were isolated from children who were under five years of age in Chennai. Indian J Med Res 2003; 117:13-8.
21. Arora S, Manjusri S. AmpC beta-lactamase producing bacterial isolates form Kolkata hospital. Indian J Med Res 2005; 122:124-33.
22. Pangon B, Bizet C, Bure A, Pichon F, Phillipon A, Ragnier B, et al. In vivo selection of cephamycin resistant, porin deficient mutants of Klebsiella pneumoniae which produce TEM-3 beta lactamase. J Infect Dis 1989; 159:1005-06.
23. Manchanda V, Singh NP. Occurrence and detection of ampC beta lactamases among gram negative clinical isolates by using a modified three-dimensional test at the Guru Tegh Bahadur Hospital, Delhi, India. J Clin Microbiol 2003; 51:415-18.
24. Skov R, Smyth R, Clausen M, et al. Evaluation of a cefoxitin 30 μg disc on isosensitest agar for the detection of methicillin resistant Staphylococcus aureus. J Antimicrob Chemother 2003; 52:204-07.
25. Felten A, Grandry B, Lagrange PH, et al. Evaluation of three techniques for the detection of low level methicillin resistant S. aureus (MRSA): a disc diffusion method with cefoxitin and moxalactum, the Vitek-2 system, and the MRSA screen latex agglutination test. J Clin Microbiol 2002; 40:2766-71.
26. Cauwelier B, Gordts B, Descheemaecker P, et al. Evaluation of the disc diffusion method with cefoxitin (30 μg) for the detection of methicillin resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 2004; 23:389-92.
27. Sanjan RK, Shah R, Chaudhary N, Singh YI. Prevalence and antimicrobial susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) in the CMS-teaching hospital: a preliminary report. JCMS-Nepal, 2010; 6(1):1-6.
28. Rajaduraipandi K, Mani KR, Panneerselvam K, Mani M, Bhaskar M, Manikandan P. Prevalence and antimicrobial susceptibility patterns of methicillin resistant Staphylococcus aureus: A multicentre study. Indian J Med Microbiol 2006; 24 (1):34-38.
29. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM. Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 2003; 21(1):49-51.
30. Onanuga A, Oyi AR, Onaolapo JA. Prevalence and susceptibility pattern of methicillin resistant Staphylococcus aureus isolates among healthy women in Zaria, Nigeria. Afr J Biotechnol 2005; 4(11):1321-24.
31. Coombs GW, Nimmo GR, Pearson JC, Christiansen KJ, Bell JM, Collignon PJ, et al. Prevalence of MRSA strains among Staphylococcus aureus which was isolated from outpatients in 2006. Commun Dis Intell 2009; 33(1):10-20.
32. Baby PS, Appala RB, Mani KR. Detection of Enterobacteriaceae producing CTX-M extended spectrum beta-lactamases from a tertiary care hospital in south India. Indian J Med Microbiol 2008; 26:163-66.
33. Luzzaro F, Mezzatesta M, Mugnaioli C, Perilli M, Stefani S, et al. Extended-Spectrum β-lactamases among enterobacteria of medical interest: Report of the Second Italian Nationwide Survey. J Clin Microbiol 2006; 44(5):16059-64.
34. Choudhary U, Aggarwal R. Extended spectrum β-lactamases (ESBL) - an emerging threat to the clinical therapeutics. Indian J Med Microbiol 2004; 22(2):75-80.
35. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infections. Infectious Disease Society of America and the Food and Drug Administration. Clin Infect Dis 1992;15:216-27.
36. Karlowsky JA, Thornsberry C, Jones ME, Sahm DF. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis 2003;36:183-87.
37. Keah SH, Wee EC, Chng KS, Keah KC. Antimicrobial susceptibility of community acquired uropathogens in the general practice. Malaysian Family Physician 2007;2:64-69.
38. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in the JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:4.
39. Manjunath GN, Prakash R, Annam V, Shetty K. The changing trends in the spectrum of the antimicrobial drug resistance pattern of uropathogens which were isolated from hospitals and community patients with urinary tract infections in Tumkur and Bangalore. Int J Biol Med Res 2011; 2(2):504-50.
40. Biswas D, Gupta P, Prasad R, Singh V, Arya M, Kumar A. Choice of antibiotics for the empirical therapy of acute cystitis in a setting of high antimicrobial resistance. Indian J Med Sci 2006;60:53-58.
41. Honderlick P, Cahen P, Gravisse J, Vignon D. Uncomplicated urinary tract infections; what about fosfomycin and nitrofurantoin in 2006?. Pathol Biol 2006;54:462-66.